AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2010
May 14, 2010
30583_dirs_2010-05-14_48e9830f-1e95-46f5-bd9b-3fef56698cb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2010-04-30
Reporting Person: Davis George Eric (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-30 | Common Stock | A | 1456 | $11.637 | Acquired | 21908 | Direct |
| 2010-05-12 | Common Stock | A | 8400 | — | Acquired | 30308 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-12 | Stock Option (right to buy) | $21.51 | A | 63000 | Acquired | 2020-05-11 | Common Stock (63000) | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of October 31, 2009 to April 30, 2010.
F2: In accordance with the ESPP, these shares have been purchased at 85% of the closing price of issuer's common stock on April 30, 2010.
F3: Restricted stock units granted on May 12, 2010. Price not applicable.
F4: Options vest 6/48ths on November 12, 2010 and 1/48th on the 12th of each month thereafter.